KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
China boardroom update - Issue 2, January 2011
While China will remain the focus of Asia's economic growth, the continuous strengthening of Chinese economy may also bring risks of overheating, excessive investments and other challenges.
Related links
RSS feeds
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.
Newsletters - Our weekly and monthly newsletters summarise industry news, market trends and updates in regulations for the China and Asia Pacific regions.